Cargando…

Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma

MiR-375 is a tumor suppressor miRNA that is downregulated in hepatocellular carcinoma (HCC). However, due to the lack of effective delivery strategies, miR-375 replacement as a therapy for HCC has not been investigated. In the present study, we have developed a straightforward strategy to deliver mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Hui-Ying, Liu, Yong, Liao, Jia-Zhi, Lin, Ju-Sheng, Li, Bin, Yuan, Wei-Gang, Lee, Robert J., Li, Lei, Xu, Chuan-Rui, He, Xing-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349944/
https://www.ncbi.nlm.nih.gov/pubmed/27880727
http://dx.doi.org/10.18632/oncotarget.13431
_version_ 1782514566633095168
author Xue, Hui-Ying
Liu, Yong
Liao, Jia-Zhi
Lin, Ju-Sheng
Li, Bin
Yuan, Wei-Gang
Lee, Robert J.
Li, Lei
Xu, Chuan-Rui
He, Xing-Xing
author_facet Xue, Hui-Ying
Liu, Yong
Liao, Jia-Zhi
Lin, Ju-Sheng
Li, Bin
Yuan, Wei-Gang
Lee, Robert J.
Li, Lei
Xu, Chuan-Rui
He, Xing-Xing
author_sort Xue, Hui-Ying
collection PubMed
description MiR-375 is a tumor suppressor miRNA that is downregulated in hepatocellular carcinoma (HCC). However, due to the lack of effective delivery strategies, miR-375 replacement as a therapy for HCC has not been investigated. In the present study, we have developed a straightforward strategy to deliver miR-375 into HCC cells by assembling miR-375 mimics on the surface of AuNPs and forming AuNP-miR-375 nanoparticles. AuNP-miR-375 exhibits high cellular uptake and preserves miR-375′s activities to suppress cellular proliferation, migration/invasion, and colony formation, and to induce apoptosis in HCC cells. Furthermore, AuNP-delivered miR-375 efficiently downregulated its target genes through RNA interference. In primary and xenograft tumor mouse models, AuNP-miR-375 showed high tumor uptake, therapeutic efficacy, and no apparent toxicity to the host mice. In conclusion, our findings indicate that AuNPs is a reliable strategy to deliver miR-375 into HCC cells and tissue, and that AuNP-miR-375 has the potential in the clinic for treatment of unresectable HCC.
format Online
Article
Text
id pubmed-5349944
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53499442017-04-06 Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma Xue, Hui-Ying Liu, Yong Liao, Jia-Zhi Lin, Ju-Sheng Li, Bin Yuan, Wei-Gang Lee, Robert J. Li, Lei Xu, Chuan-Rui He, Xing-Xing Oncotarget Research Paper MiR-375 is a tumor suppressor miRNA that is downregulated in hepatocellular carcinoma (HCC). However, due to the lack of effective delivery strategies, miR-375 replacement as a therapy for HCC has not been investigated. In the present study, we have developed a straightforward strategy to deliver miR-375 into HCC cells by assembling miR-375 mimics on the surface of AuNPs and forming AuNP-miR-375 nanoparticles. AuNP-miR-375 exhibits high cellular uptake and preserves miR-375′s activities to suppress cellular proliferation, migration/invasion, and colony formation, and to induce apoptosis in HCC cells. Furthermore, AuNP-delivered miR-375 efficiently downregulated its target genes through RNA interference. In primary and xenograft tumor mouse models, AuNP-miR-375 showed high tumor uptake, therapeutic efficacy, and no apparent toxicity to the host mice. In conclusion, our findings indicate that AuNPs is a reliable strategy to deliver miR-375 into HCC cells and tissue, and that AuNP-miR-375 has the potential in the clinic for treatment of unresectable HCC. Impact Journals LLC 2016-11-17 /pmc/articles/PMC5349944/ /pubmed/27880727 http://dx.doi.org/10.18632/oncotarget.13431 Text en Copyright: © 2016 Xue et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Xue, Hui-Ying
Liu, Yong
Liao, Jia-Zhi
Lin, Ju-Sheng
Li, Bin
Yuan, Wei-Gang
Lee, Robert J.
Li, Lei
Xu, Chuan-Rui
He, Xing-Xing
Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
title Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
title_full Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
title_fullStr Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
title_full_unstemmed Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
title_short Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma
title_sort gold nanoparticles delivered mir-375 for treatment of hepatocellular carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349944/
https://www.ncbi.nlm.nih.gov/pubmed/27880727
http://dx.doi.org/10.18632/oncotarget.13431
work_keys_str_mv AT xuehuiying goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma
AT liuyong goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma
AT liaojiazhi goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma
AT linjusheng goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma
AT libin goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma
AT yuanweigang goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma
AT leerobertj goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma
AT lilei goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma
AT xuchuanrui goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma
AT hexingxing goldnanoparticlesdeliveredmir375fortreatmentofhepatocellularcarcinoma